These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 23357493)

  • 21. Treatment of hepatocellular carcinoma.
    Blum HE
    Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):129-45. PubMed ID: 15757809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pretransplant Intra-arterial Liver-Directed Therapy Does Not Increase the Risk of Hepatic Arterial Complications in Liver Transplantation: A Single-Center 10-Year Experience.
    Kallini JR; Gabr A; Ali R; Abouchaleh N; Riaz A; Baker T; Kulik L; Caicedo J; Salem R; Lewandowski RJ
    Cardiovasc Intervent Radiol; 2018 Feb; 41(2):231-238. PubMed ID: 28900709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on transarterial approaches to locoregional treatment in hepatocellular carcinoma.
    Delhaye C; Hendlisz A; Vouche M
    Curr Opin Oncol; 2019 Jul; 31(4):339-345. PubMed ID: 30896451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost effectiveness of radioembolization compared with conventional transarterial chemoembolization for treatment of hepatocellular carcinoma.
    Rostambeigi N; Dekarske AS; Austin EE; Golzarian J; Cressman EN
    J Vasc Interv Radiol; 2014 Jul; 25(7):1075-84. PubMed ID: 24861664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intra-arterial therapies for hepatocellular carcinoma: where do we stand?
    Liapi E; Geschwind JF
    Ann Surg Oncol; 2010 May; 17(5):1234-46. PubMed ID: 20405328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
    Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
    J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transarterial radioembolization for hepatocellular carcinoma: An update and perspectives.
    Sacco R; Mismas V; Marceglia S; Romano A; Giacomelli L; Bertini M; Federici G; Metrangolo S; Parisi G; Tumino E; Bresci G; Corti A; Tredici M; Piccinno M; Giorgi L; Bartolozzi C; Bargellini I
    World J Gastroenterol; 2015 Jun; 21(21):6518-25. PubMed ID: 26074690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transarterial therapy: an evolving treatment modality of hepatocellular carcinoma.
    Jazieh KA; Arabi M; Khankan AA
    Saudi J Gastroenterol; 2014; 20(6):333-41. PubMed ID: 25434313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intra-Arterial Therapies for Liver Masses: Data Distilled.
    Molvar C; Lewandowski RJ
    Radiol Clin North Am; 2015 Sep; 53(5):973-84. PubMed ID: 26321448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcatheter arterial embolic therapies for hepatocellular carcinoma: a literature review.
    Nishikawa H; Kita R; Kimura T; Osaki Y
    Anticancer Res; 2014 Dec; 34(12):6877-86. PubMed ID: 25503113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical treatment of hepatocellular carcinoma.
    Václav T
    Klin Onkol; 2020; 33(Supplementum 3):30-33. PubMed ID: 33213163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons.
    Makary MS; Ramsell S; Miller E; Beal EW; Dowell JD
    World J Gastroenterol; 2021 Nov; 27(43):7462-7479. PubMed ID: 34887643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma.
    Kallini JR; Gabr A; Salem R; Lewandowski RJ
    Adv Ther; 2016 May; 33(5):699-714. PubMed ID: 27039186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transarterial therapies for primary liver tumors.
    Talenfeld AD; Sista AK; Madoff DC
    Surg Oncol Clin N Am; 2014 Apr; 23(2):323-51. PubMed ID: 24560113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Radioembolization in Bridging and Downstaging Hepatocellular Carcinoma to Curative Therapy.
    Titano J; Voutsinas N; Kim E
    Semin Nucl Med; 2019 May; 49(3):189-196. PubMed ID: 30954184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transarterial therapies for hepatocellular carcinoma.
    Sangro B; D'Avola D; Iñarrairaegui M; Prieto J
    Expert Opin Pharmacother; 2011 May; 12(7):1057-73. PubMed ID: 21470073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arterially directed therapies for hepatocellular carcinoma.
    Shah RP; Brown KT; Sofocleous CT
    AJR Am J Roentgenol; 2011 Oct; 197(4):W590-602. PubMed ID: 21940531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Yttrium-90 Radioembolization for Hepatocellular Carcinoma.
    Hickey RM; Lewandowski RJ; Salem R
    Semin Nucl Med; 2016 Mar; 46(2):105-8. PubMed ID: 26897714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Drug-Eluting Embolics versus Conventional Transarterial Chemoembolization for the Treatment of Patients with Unresectable Hepatocellular Carcinoma: A Cost-Effectiveness Analysis.
    Wu X; Chapiro J; Malhotra A; Kothary N
    J Vasc Interv Radiol; 2021 Jan; 32(1):2-12.e1. PubMed ID: 33160827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma.
    Saviano A; Iezzi R; Giuliante F; Salvatore L; Mele C; Posa A; Ardito F; De Gaetano AM; Pompili M;
    J Vasc Interv Radiol; 2017 Nov; 28(11):1512-1519. PubMed ID: 28734848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.